Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$12.09 - $14.68 $129,084 - $156,738
-10,677 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$13.25 - $15.13 $141,470 - $161,543
10,677 New
10,677 $145,000
Q2 2021

Aug 04, 2021

SELL
$12.97 - $16.15 $212,046 - $264,036
-16,349 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$13.59 - $18.54 $4,905 - $6,692
-361 Reduced 2.16%
16,349 $228,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $238,953 - $313,145
16,710 New
16,710 $313,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.